Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Esperanza Pérez-Pastrana is active.

Publication


Featured researches published by Esperanza Pérez-Pastrana.


Journal of Virology | 2000

Influenza Virus Matrix Protein Is the Major Driving Force in Virus Budding

Paulino Gómez-Puertas; Carmen Albo; Esperanza Pérez-Pastrana; Amparo Vivo; Agustín Portela

ABSTRACT To get insights into the role played by each of the influenza A virus polypeptides in morphogenesis and virus particle assembly, the generation of virus-like particles (VLPs) has been examined in COS-1 cell cultures expressing, from recombinant plasmids, different combinations of the viral structural proteins. The presence of VLPs was examined biochemically, following centrifugation of the supernatants collected from transfected cells through sucrose cushions and immunoblotting, and by electron-microscopic analysis. It is demonstrated that the matrix (M1) protein is the only viral component which is essential for VLP formation and that the viral ribonucleoproteins are not required for virus particle formation. It is also shown that the M1 protein, when expressed alone, assembles into virus-like budding particles, which are released in the culture medium, and that the recombinant M1 protein accumulates intracellularly, forming tubular structures. All these results are discussed with regard to the roles played by the virus polypeptides during virus assembly.


Journal of General Virology | 1999

Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins

Paulino Gómez-Puertas; Mena I; Castillo M; Amparo Vivo; Esperanza Pérez-Pastrana; Agustín Portela

It has previously been demonstrated in this laboratory that an influenza virus-like chloramphenicol acetyltransferase (CAT) RNA could be expressed in COS-1 cells that synthesized all ten influenza A virus-encoded proteins from recombinant plasmids. It was also shown that supernatant fluids harvested from these cultures contained virus-like particles (VLPs) that could deliver an enclosed CAT RNA to MDCK cells. Here, it is shown that the levels of expression of the reporter gene in the COS-1 and/or MDCK cells can be altered drastically by modifying the concentrations of the recombinant plasmids transfected in the COS-1 cells. Thus, it was observed that overexpression of NS2 reduced CAT expression in COS-1 cells, whereas overexpression of M2 and NS1 proteins dramatically decreased transmission of the CAT RNA to the MDCK cultures. These results are discussed with reference to the roles of these proteins during virus replication. From these experiments, a ratio of transfected plasmids was found that increased the efficiency of the previously described system by 50-100-fold. Under these optimized conditions, it was demonstrated that VLPs can be formed in the absence of neuraminidase expression and that these VLPs remained aggregated to each other and to cell membranes. Moreover, it is shown that CAT RNA transmission was dependent on specific interactions of the ribonucleoprotein complex with other viral structural polypeptides. These data demonstrate the usefulness of this encapsidation-packaging system for the study of different aspects of the influenza virus life-cycle.


Parasites & Vectors | 2012

Detection of a new insect flavivirus and isolation of Aedes flavivirus in Northern Italy

David Roiz; Ana Vázquez; Fausta Rosso; Daniele Arnoldi; Matteo Girardi; Laureano Cuevas; Esperanza Pérez-Pastrana; María Paz Sánchez-Seco; Antonio Tenorio; Annapaola Rizzoli

BackgroundDuring recent years, numerous novel ‘insect flaviviruses’ have been discovered in natural mosquito populations. In a previous study we described the presence of flavivirus DNA sequences integrated in Aedes albopictus (Asian tiger mosquito) populations from Northern Italy in 2007.MethodsDuring 2008 we collected and tested Aedes females for flavivirus presence and developed phylogenetic analysis, virus isolation, electron microscopy studies and RNAse treatments.ResultsWe detected a high prevalence of flavivirus in Ae. albopictus (77.5%). The phylogenetic analysis identified the insect flavivirus sequences as Aedes flavivirus (AEFV) recently described in Japan, and that may have been introduced in Italy travelling with the tiger mosquito. Some of these pools grew in C6/36 cells, producing cytopathic effects, and the RNase treatment results showed the presence of the detected sequences in RNA forms. Furthermore, we detected a new insect flavivirus in one pool of Aedes cinereus/geminus mosquitoes. Phylogenetic analysis of this virus shows that it forms a distinct cluster within the clade of insect flavivirus.ConclusionsThis is the first study to report a high prevalence, to describe the seasonal activity and an isolation of the insect flavivirus Aedes flavivirus in Europe. Moreover we describe the detection of a new insect flavivirus detected from Ae. cinereus mosquitoes from Italy. These flavivirus may be common, ubiquitous and diverse in nature and we discuss the implications of the insect flavivirus group in virus evolution and transmission.


Journal of Clinical Microbiology | 2007

Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1.1)

Berta Rodés; Julie Sheldon; Carlos Toro; Laureano Cuevas; Esperanza Pérez-Pastrana; Inmaculada Herrera; Vincent Soriano

ABSTRACT No commercial viral load assay has yet been approved for use for measurement of human immunodeficiency virus type 2 (HIV-2) RNA levels in plasma. We assessed the performance of the NucliSens EasyQ (version 1.1) assay (EasyQ; bioMérieux, Boxtel, The Netherlands) to quantify HIV-2 viremia. A viral stock was prepared from an HIV-2 (subtype A)-infected patient. Culture supernatant was subjected to viral particle counting by electron microscopy. Serial dilutions of the viral stock were made in HIV-negative plasma and were used to test EasyQ for its sensitivity, linearity, and reproducibility. RNA was quantified by the NucliSens EasyQ (version 1.1) assay. Plasma samples from 75 HIV-2-infected patients were further tested. EasyQ was able to quantify HIV-2 RNA in a reproducible manner. Overall, estimates of the number of HIV-2 RNA copies/ml obtained with EasyQ were lower than those obtained by electron microscopy; however, the differences were always less than 0.7 log (mean, 0.55 ± 0.19 log10). The assay showed good linearity (r2 = 0.964; P < 0.0001). The agreement between both measures was assessed by use of a Bland-Altman plot; the narrow limits (0.158 to 0.952), defined as the mean difference ± 2 standard deviations, indicated good agreement. The reproducibility was also good, since the between-run coefficients of variation were 1.49, 3.60, and 12.25% for samples containing 6.30, 4.30, and 2.30 log10 HIV-2 RNA copies/ml, respectively. HIV-2 RNA was detected in 34 of 75 (45%) plasma specimens (mean, 2.72 log RNA copies/ml; range, 1.74 to 4.11 log RNA copies/ml); the rest of the specimens were considered to have undetectable viremia. A negative correlation was found between the number of HIV-2 RNA copies/ml and CD4 counts. In summary, EasyQ was shown to be reliable for the measurement of plasma HIV-2 subtype A RNA levels and may be a feasible tool for routine clinical monitoring of HIV-2 subtype A-infected patients.


Chemosphere | 2013

Converging hazard assessment of gold nanoparticles to aquatic organisms

Jesús Pablo García-Cambero; Mercedes Núñez García; Gema Díaz López; Ana López Herranz; Laureano Cuevas; Esperanza Pérez-Pastrana; Judith Sendra Cuadal; Marc Ramis Castelltort; Argelia Castaño Calvo

The gold nanoparticles (Au-NPs) are being increasingly used because of their huge diversity of applications, and consequently, elevated levels in the environment are expected. However, due to their physico-chemical properties and functionalization a high variety of Au-NPs can be found, and complete toxicological information for each type of Au-NPs still lacks, and even, the toxicological information for the same species is sometimes contradictory. Therefore, hazard assessment should be done case by case. Hence, the objective of this study was to obtain ecotoxicological information of the same Au-NPs in aquatic organisms and to find a rationale for Au-NPs toxicity. For such a purpose, bare and hyaluronic acid capped Au-NPs (12.5 nm) along with Au-NPs bulk material were tested on freshwater algae, Daphnia and zebrafish. Results showed that while gold nanoparticles were found to be harmless to the tested organisms, the soluble gold showed to be toxic to algae and Daphnia, with an LC50 between 1 and 2 mg L(-1). Comparing our results with those gathered in the literature, it appears that a common hazard assessment of Au-NPs on the studied organisms can be elucidated.


Journal of General Virology | 2015

Wide detection of Aedes flavivirus in north-eastern Italy - a European hotspot of emerging mosquito- borne diseases

Michela Grisenti; Ana Vázquez; Laura Herrero; Laureano Cuevas; Esperanza Pérez-Pastrana; Daniele Arnoldi; Roberto Rosà; Gioia Capelli; Antonio Tenorio; María Paz Sánchez-Seco; Annapaola Rizzoli

The pattern of flavivirus infection in mosquitoes belonging to the genera Aedes and Culex collected in two regions of north-eastern Italy (Trentino and Veneto) was assessed. Mosquitoes were collected during 2012 and screened for flaviviruses using a generic reverse transcription-nested-PCR targeted on a region of the non-structural NS5 gene. The phylogenetic analysis was performed on a fragment of ~1000 bp. Virus isolation was attempted in C6/36 insect cell lines and the infected cell cultures were studied by electron microscopy. We detected a wide distribution of Aedes flavivirus (AeFV) in Aedes albopictus, with higher infection prevalence in Trentino than in Veneto. In Culex pipiens collected in Veneto, we detected a new sequence of an insect-specific flavivirus and one of Usutu virus. Interestingly, we detected AeFV in C. pipiens, for the first time to our knowledge, in both regions. Viral isolation in cell culture was successful for AeFV. AeFV sequences found in Veneto showed a high percentage of similarity to those detected in Trentino and to those previously reported in other areas of northern Italy. Co-infections with different flaviviruses were not detected.


Cellular Microbiology | 2015

Localization of serum resistance‐associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei

Jean-Mathieu Bart; Carlos Cordon-Obras; Isabel Vidal; Jennifer Reed; Esperanza Pérez-Pastrana; Laureano Cuevas; Mark C. Field; Mark Carrington; Miguel Navarro

African trypanosomes infect a broad range of mammals, but humans and some higher primates are protected by serum trypanosome lytic factors that contain apolipoprotein L1 (ApoL1). In the human‐infective subspecies of Trypanosoma brucei, Trypanosoma brucei rhodesiense, a gene product derived from the variant surface glycoprotein gene family member, serum resistance‐associated protein (SRA protein), protects against ApoL1‐mediated lysis. Protection against trypanosome lytic factor requires the direct interaction between SRA protein and ApoL1 within the endocytic apparatus of the trypanosome, but some uncertainty remains as to the precise mechanism and location of this interaction. In order to provide more insight into the mechanism of SRA‐mediated resistance to trypanosome lytic factor, we assessed the localization of SRA in T. b. rhodesiense EATRO3 using a novel monoclonal antibody raised against SRA together with a set of well‐characterized endosomal markers. By three‐dimensional deconvolved immunofluorescence single‐cell analysis, combined with double‐labelling immunoelectron microscopy, we found that ≈ 50% of SRA protein localized to the lysosome, with the remaining population being distributed through the endocytic pathway, but apparently absent from the flagellar pocket membrane. These data suggest that the SRA/trypanolytic factor interaction is intracellular, with the concentration within the endosomes potentially crucial for ensuring a high efficiency.


Molecular Biology Reports | 2010

Molecular cloning and characterisation of the RESA gene, a marker of genetic diversity of Plasmodium falciparum

Eva M. Moyano; Luis Miguel González; Laureano Cuevas; Esperanza Pérez-Pastrana; Ysmael Santa-Maria; Agustín Benito

To identity immunodiagnostic antigen genes, a Plasmodium falciparum (Dd2 clone) expression library was screened using human immune sera. The ring-infected erythrocyte surface antigen (RESA) was isolated: this antigen of the resistant clone presents repeat tandem sequences like the 3D7 clone, albeit in different numbers. RESA has been studied as a marker of genetic diversity, with different sizes being observed in different isolates and clones of Plasmodium falciparum. The native protein was localised in cultures by western-blot and immuno-transmission electron microscopy. The antigenicity of RESA was evaluated by ELISA, using the carboxy-terminal repeat region as antigen. The assay’s sensitivity and specificity were 78.2 and 94% respectively.


Pediatric Dermatology | 2018

Erythema multiforme after orf virus infection

Angella López-Cedeño; Gustavo Cañedo; Nicole Knöpfel; Isabel Colmenero; Esperanza Pérez-Pastrana; Antonio Torrelo

The case of a 6‐year‐old boy with multiple, target‐shaped lesions and a crusted nodule on his right index finger is presented. Based on clinical findings and the patients recent contact with sheep and goats, a diagnosis of orf disease associated with erythema multiforme was suspected. Microscopy studies confirmed the presence of parapoxvirus in the primary lesion. Orf‐induced erythema multiforme is a rare complication of orf in children, possibly related to the presence of orf virus DNA in erythema multiforme lesions.


Infection and Immunity | 2002

In vitro culture of Borrelia garinii results in loss of flagella and decreased invasiveness.

Ricela E. Sellek; Raquel Escudero; Horacio Gil; Isabel Rodríguez; Escolástica Chaparro; Esperanza Pérez-Pastrana; Amparo Vivo; Pedro Anda

Collaboration


Dive into the Esperanza Pérez-Pastrana's collaboration.

Top Co-Authors

Avatar

Laureano Cuevas

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Amparo Vivo

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Agustín Benito

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Agustín Portela

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Ana Vázquez

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Antonio Tenorio

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Eva M. Moyano

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Luis Miguel González

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ysmael Santa-Maria

Instituto de Salud Carlos III

View shared research outputs
Researchain Logo
Decentralizing Knowledge